3W2D
Crystal Structure of Staphylococcal Eenterotoxin B in complex with a novel neutralization monoclonal antibody Fab fragment
Summary for 3W2D
Entry DOI | 10.2210/pdb3w2d/pdb |
Descriptor | Enterotoxin type B, Monoclonal Antibody 3E2 Fab figment light chain, Monoclonal Antibody 3E2 Fab figment heavy chain, ... (5 entities in total) |
Functional Keywords | staphylococcal eenterotoxin b, immune system |
Biological source | Staphylococcus aureus More |
Cellular location | Secreted: P01552 |
Total number of polymer chains | 3 |
Total formula weight | 76411.20 |
Authors | Liang, S.Y.,Hu, S.,Dai, J.X.,Guo, Y.J.,Lou, Z.Y. (deposition date: 2012-11-28, release date: 2013-12-25, Last modification date: 2024-10-30) |
Primary citation | Xia, T.,Liang, S.,Wang, H.,Hu, S.,Sun, Y.,Yu, X.,Han, J.,Li, J.,Guo, S.,Dai, J.,Lou, Z.,Guo, Y. Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site. MAbs, 6:119-129, 2014 Cited by PubMed Abstract: Staphylococcal enterotoxin (SE) B is among the potent toxins produced by Staphylococcus aureus that cause toxic shock syndrome (TSS), which can result in multi-organ failure and death. Currently, neutralizing antibodies have been shown to be effective immunotherapeutic agents against this toxin, but the structural basis of the neutralizing mechanism is still unknown. In this study, we generated a neutralizing monoclonal antibody, 3E2, against SEB, and analyzed the crystal structure of the SEB-3E2 Fab complex. Crystallographic analysis suggested that the neutralizing epitope overlapped with the MHC II molecule binding site on SEB, and thus 3E2 could inhibit SEB function by preventing interaction with the MHC II molecule. Mutagenesis studies were done on SEB, as well as the related Staphylococcus aureus toxins SEA and SEC. These studies revealed that tyrosine (Y)46 and lysine (K)71 residues of SEB are essential to specific antibody-antigen recognition and neutralization. Substitution of Y at SEA glutamine (Q)49, which corresponds to SEB Y46, increased both 3E2's binding to SEA in vitro and the neutralization of SEA in vivo. These results suggested that SEB Y46 is responsible for distinguishing SEB from SEA. These findings may be helpful for the development of antibody-based therapy for SEB-induced TSS. PubMed: 24423621DOI: 10.4161/mabs.27106 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.1 Å) |
Structure validation
Download full validation report